- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.5 EX-3.5
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.73 EX-10.73
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- EX-FILING FEES Ex-filing Fees
- 6 Sep 22 EFFECT Notice of effectiveness
- 2 Sep 22 424B3 Prospectus supplement
- 19 Aug 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 Jul 22 S-4 Registration of securities issued in business combination transactions
Exhibit 99.2
July 15, 2022
Zymeworks Delaware Inc.
108 Patriot Drive, Suite A
Middletown, Delaware 19709
Consent to Reference in Proxy Statement/Prospectus
Zymeworks Delaware Inc. (the “Company”) is filing a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included in such Registration Statement as a future member of the board of directors of the Company, such service to commence upon the effective time of the redomicile transaction described in the proxy statement/prospectus.
| Sincerely, |
/s/ Kenneth Hillan |
| Kenneth Hillan |
Signature Page to Director Consent to Reference